Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls

Bone

Volumn 45, Issue 1, 2009, Pages 104-109

  Russell, Melissa ^a   Stark, Jenna ^a   Nayak, Shriddha ^a   Miller, Karen K ^a   Herzog, David B ^a   Klibanski, Anne ^a   Misra, Madhusmita ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adolescents; Athletes; Bone density; Bone turnover; Peptide YY

Indexed keywords

ADIPONECTIN; AMINO TERMINAL TELOPEPTIDE; ESTRADIOL; GHRELIN; LEPTIN; PEPTIDE YY; SOMATOMEDIN C; TESTOSTERONE;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; ATHLETE; BODY MASS; BONE DENSITY; BONE METABOLISM; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; EATING DISORDER; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; LUMBAR SPINE; MENSTRUATION; OSSIFICATION; OSTEOLYSIS; PHYSICAL ACTIVITY; PREDICTION; SCORING SYSTEM;

ADIPONECTIN; ADOLESCENT; AMENORRHEA; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; OVARY; PEPTIDE YY; REGRESSION ANALYSIS; SPORTS; STEROIDS;

EID: 67349191036     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.03.668     Document Type: Article

References (49)

1. De Souza M.J., West S.L., Jamal S.A., Hawker G.A., Gundberg C.M., and Williams N.I. The presence of both an energy deficiency and estrogen deficiency exacerbate alterations of bone metabolism in exercising women. Bone 43 (2008) 140-148
2. Christo K., Prabhakaran R., Lamparello B., Cord J., Miller K., Goldstein M., et al. Bone metabolism in adolescent amenorrheic and eumenorrheic athletes and controls. Pediatrics 121 (2008) 1127-1136
3. Christo K., Cord J., Mendes N., Miller K., Goldstein M., Klibanksi A., et al. Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross-sectional study. Clin. Endocrinol. 69 (2008) 628-633
4. Kluge M., Schussler P., Uhr M., Yassouridis A., and Steiger A. Ghrelin suppresses secretion of luteinizing hormone in humans. J. Clin. Endocrinol. Metab. 92 (2007) 3202-3205
5. Welt C.K., Chan J.L., Bullen J., Murphy R., Smith P., DePaoli A.M., et al. Recombinant human leptin in women with hypothalamic amenorrhea. N. Engl. J. Med. 351 (2004) 987-997
6. Misra M., Miller K.K., Tsai P., Gallagher K., Lin A., Lee N., et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J. Clin. Endocrinol. Metab. 91 (2005) 1027-1033
7. Cambuli V.M., Musiu M.C., Incani M., Paderi M., Serpe R., Marras V., et al. Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. J. Clin. Endocrinol. Metab. 93 (2008) 3051-3057
8. Pinilla L., Fernandez-Fernandez R., Roa J., Castellano J.M., Tena-Sempere M., and Aguilar E. Selective role of neuropeptide Y receptor subtype Y2 in the control of gonadotropin secretion in the rat. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E1385-E1392
9. Rodriguez-Pacheco F., Martinez-Fuentes A.J., Tovar S., Pinilla L., Tena-Sempere M., Dieguez C., et al. Regulation of pituitary cell function by adiponectin. Endocrinology 148 (2007) 401-410
10. Baldock P.A., Sainsbury A., Couzens M., Enriquez R.F., Thomas G.P., Gardiner E.M., et al. Hypothalamic Y2 receptors regulate bone formation. J. Clin. Invest. 109 (2002) 915-921
11. Luo X.H., Guo L.J., Xie H., Yuan L.Q., Wu X.P., Zhou H.D., et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J. Bone. Miner. Res. 21 (2006) 1648-1656
12. Luo X.H., Guo L.J., Yuan L.Q., Xie H., Zhou H.D., Wu X.P., et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp. Cell. Res. 309 (2005) 99-109
13. Huda M.S., Wilding J.P., and Pinkney J.H. Gut peptides and the regulation of appetite. Obes. Rev. 7 (2006) 163-182
14. Ballantyne G.H. Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions. Obes. Surg. 16 (2006) 651-658
15. Grandt D., Teyssen S., Schimiczek M., Reeve Jr. J.R., Feth F., Rascher W., et al. Novel generation of hormone receptor specificity by amino terminal processing of peptide YY. Biochem. Biophys. Res. Commun. 186 (1992) 1299-1306
16. Keire D.A., Mannon P., Kobayashi M., Walsh J.H., Solomon T.E., and Reeve Jr. J.R. Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am. J. Physiol. Gastrointest. Liver. Physiol. 279 (2000) G126-G131
17. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., et al. Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med. 349 (2003) 941-948
18. Fernandez-Fernandez R., Aguilar E., Tena-Sempere M., and Pinilla L. Effects of polypeptide YY(3-36) upon luteinizing hormone-releasing hormone and gonadotropin secretion in prepubertal rats: in vivo and in vitro studies. Endocrinology 146 (2005) 1403-1410
19. Misra M., Miller K.K., Cord J., Prabhakaran R., Herzog D.B., Goldstein M., et al. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J. Clin. Endocrinol. Metab. 92 (2007) 2046-2052
20. Pannacciulli N., Bunt J.C., Ortega E., Funahashi T., Salbe A.D., Bogardus C., et al. Lower total fasting plasma adiponectin concentrations are associated with higher metabolic rates. J. Clin. Endocrinol. Metab. 91 (2006) 1600-1603
21. Lenchik L., Register T.C., Hsu F.C., Lohman K., Nicklas B.J., Freedman B.I., et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33 (2003) 646-651
22. Rickenlund A., Carlstrom K., Ekblom B., Brismar T.B., Von Schoultz B., and Hirschberg A.L. Effects of oral contraceptives on body composition and physical performance in female athletes. J. Clin. Endocrinol. Metab. 89 (2004) 4364-4370
23. Herman-Giddens M.E., Slora E.J., Wasserman R.C., Bourdony C.J., Bhapkar M.V., Koch G.G., et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 99 (1997) 505-512
24. Ogden C.L., Kuczmarski R.J., Flegal K.M., Mei Z., Guo S., Wei R., et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109 (2002) 45-60
25. Aaron D.J., Kriska A.M., Dearwater S.R., Cauley J.A., Metz K.F., and LaPorte R.E. Reproducibility and validity of an epidemiologic questionnaire to assess past year physical activity in adolescents. Am. J. Epidemiol. 142 (1995) 191-201
26. Greulich W.W., and Pyle S.I. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 2nd ed. (1959), Stanford Univ. Press, Stanford, Calif
27. Kelly T., Specker B., Binkley T., Zemel B., Leonard M., Kalkwarf H., et al. Pediatric BMD Reference Database for U.S. White Children (2005), Children's Bone Health Abstract, Sorrento, Italy
28. Ward K.A., Ashby R.L., Roberts S.A., Adams J.E., and Zulf Mughal M. UK reference data for the Hologic QDR Discovery dual-energy X ray absorptiometry scanner in healthy children and young adults aged 6-17 years. Arch. Dis. Child. 92 (2007) 53-59
29. Utz A.L., Lawson E.A., Misra M., Mickley D., Gleysteen S., Herzog D.B., et al. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 43 (2008) 135-139
30. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392 (1998) 398-401
31. Farooqi I.S., Matarese G., Lord G.M., Keogh J.M., Lawrence E., Agwu C., et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110 (2002) 1093-1103
32. Strobel A., Issad T., Camoin L., Ozata M., and Strosberg A.D. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 18 (1998) 213-215
33. Scheid J.L., Williams N.I., West S.L., VanHeest J.L., and De Souza M.J. Elevated PYY is associated with energy deficiency and indices of subclinical disordered eating in exercising women with hypothalamic amenorrhea. Appetite 52 (2009) 184-192
34. Misra M., Prabhakaran R., Miller K.K., Tsai P., Lin A., Lee N., et al. Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr. Res. 59 (2006) 598-603
35. Pielecka J., Quaynor S.D., and Moenter S.M. Androgens increase gonadotropin-releasing hormone neuron firing activity in females and interfere with progesterone negative feedback. Endocrinology 147 (2006) 1474-1479
36. Sullivan S.D., and Moenter S.M. Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7129-7134
37. Inui A., Inoue T., Sakatani N., Oya M., Morioka H., Mizuno N., et al. Biological actions of peptide YY: effects on endocrine pancreas, pituitary-adrenal axis, and plasma catecholamine concentrations in the dog. Horm. Metab. Res. 19 (1987) 353-357
38. Breen K.M., Davis T.L., Doro L.C., Nett T.M., Oakley A.E., Padmanabhan V., et al. Insight into the neuroendocrine site and cellular mechanism by which cortisol suppresses pituitary responsiveness to gonadotropin-releasing hormone. Endocrinology 149 (2008) 767-773
39. Oakley A.E., Breen K.M., Clarke I.J., Karsch F.J., Wagenmaker E.R., and Tilbrook A.J. Cortisol reduces gonadotropin-releasing hormone pulse frequency in follicular phase ewes: influence of ovarian steroids. Endocrinology 150 (2009) 341-349
40. Jones G., Ma D., and Cameron F. Bone density interpretation and relevance in Caucasian children aged 9-17 years of age: insights from a population-based fracture study. J. Clin. Densitom. 9 (2006) 202-209
41. Wortley K.E., Garcia K., Okamoto H., Thabet K., Anderson K.D., Shen V., et al. Peptide YY regulates bone turnover in rodents. Gastroenterology 133 (2007) 1534-1543
42. Wong I., Enriquez R., Boey D., Sainsbury A., Herzog H., Eisman J., et al. PYY deletion increases bone formation in mice. 18th Annual Scientific Meeting of the Australian & New Zealand Bone & Mineral Society (2008). http://www.anzbms.org.au/asm2008 www.anzbms.org.au/asm2008
43. Fukushima N., Hanada R., Teranishi H., Fukue Y., Tachibana T., Ishikawa H., et al. Ghrelin directly regulates bone formation. J. Bone. Miner. Res. 20 (2005) 790-798
44. Misra M., Miller K.K., Bjornson J., Hackman A., Aggarwal A., Chung J., et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J. Clin. Endocrinol. Metab. 88 (2003) 5615-5623
45. Baldock P.A., Sainsbury A., Couzens M., Enriquez R.F., Thomas G.P., Gardiner E.M., et al. Hypothalamic Y2 receptors regulate bone formation. J. Clin. Invest. 109 (2002) 915-921
46. Misra M., Aggarwal A., Miller K.K., Almazan C., Worley M., Soyka L.A., et al. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 114 (2004) 1574-1583
47. Riggs B. The mechanisms of estrogen regulation of bone resorption. J. Clin. Invest. 106 (2000) 1203-1204
48. Baek K., and Bloomfield S.A. Beta-adrenergic blockade and leptin replacement effectively mitigate disuse bone loss. J. Bone. Miner. Res. (2008)
49. Giustina A., Mazziotti G., and Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29 (2008) 535-559